Cqs Cayman LP Position in Monsanto Co New (MON) Has Increased as Valuation Rose

July 14, 2018 - By Bradley Stiles

Monsanto Company (NYSE:MON) LogoInvestors sentiment decreased to 0.75 in 2018 Q1. Its down 0.06, from 0.81 in 2017Q4. It turned negative, as 70 investors sold MON shares while 339 reduced holdings. 72 funds opened positions while 233 raised stakes. 311.73 million shares or 1.80% less from 317.44 million shares in 2017Q4 were reported. Sun Life Financial owns 754 shares or 0% of their US portfolio. Charter Tru Co holds 9,350 shares. Marco Inv Ltd Liability Co reported 0.15% of its portfolio in Monsanto Company (NYSE:MON). Ionic Cap Mngmt Ltd Liability has 0.04% invested in Monsanto Company (NYSE:MON) for 4,873 shares. Iowa-based Cambridge Advisors Inc has invested 0.01% in Monsanto Company (NYSE:MON). Great West Life Assurance Can stated it has 0.2% in Monsanto Company (NYSE:MON). Dimensional Fund Advsr LP holds 987,754 shares. Tiaa Cref Ltd reported 0.12% of its portfolio in Monsanto Company (NYSE:MON). Mercer Cap Advisers Inc stated it has 184 shares or 0.02% of all its holdings. 18,452 were accumulated by Meiji Yasuda Life Insurance. S Muoio And Commerce Ltd Liability Corp holds 43,100 shares. Bahl And Gaynor Inc reported 3,018 shares. Harvest Lc owns 38,000 shares. Twin Securities Inc owns 8.06% invested in Monsanto Company (NYSE:MON) for 402,654 shares. Highvista Strategies Ltd Company owns 134,117 shares.

Michael Hintze increased its stake in Monsanto Co New (MON) by 432.02% based on its latest 2018Q1 regulatory filing with the SEC. Cqs Cayman Lp bought 715,000 shares as the company’s stock rose 2.93% while stock markets declined. The hedge fund run by Michael Hintze held 880,500 shares of the agricultural chemicals company at the end of 2018Q1, valued at $102.75 million, up from 165,500 at the end of the previous reported quarter. Cqs Cayman Lp who had been investing in Monsanto Co New for a number of months, seems to be bullish on the $56.46 billion market cap company. The stock increased 0.02% or $0.02 during the last trading session, reaching $127.95. About 7.06 million shares traded or 69.45% up from the average. Monsanto Company (NYSE:MON) has risen 8.56% since July 14, 2017 and is uptrending. It has underperformed by 4.01% the S&P500.

Cqs Cayman Lp, which manages about $2.17B US Long portfolio, decreased its stake in Anthem Inc (Prn) by 1.75M shares to 4.50 million shares, valued at $13.68M in 2018Q1, according to the filing. It also reduced its holding in Ctrip Com Intl Ltd (Prn) by 11.04M shares in the quarter, leaving it with 27.02 million shares, and cut its stake in Under Armour Inc (Put) (NYSE:UA).

Monsanto Company (NYSE:MON) Ratings Coverage

Among 3 analysts covering Monsanto (NYSE:MON), 0 have Buy rating, 1 Sell and 2 Hold. Therefore 0 are positive. Monsanto has $128.0 highest and $12800 lowest target. $128’s average target is 0.04% above currents $127.95 stock price. Monsanto had 3 analyst reports since January 17, 2018 according to SRatingsIntel. Argus Research downgraded the stock to “Sell” rating in Monday, April 16 report. Wells Fargo maintained Monsanto Company (NYSE:MON) on Wednesday, January 17 with “Hold” rating. BMO Capital Markets downgraded Monsanto Company (NYSE:MON) rating on Monday, April 9. BMO Capital Markets has “Hold” rating and $12800 target.

Monsanto Company (NYSE:MON) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: